← back to search

Feng Xu

University of Science and Technology of China · CN
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, RNA modifications and cancer, and Cancer-related molecular mechanisms research.
h-index
40
citations
6,250
works
185
NIH funding
primary concept
email

Recent publications

USP53 promotes NOTCH2-induced neuroinflammation in Alzheimer's disease.
2026cited by 0position: contributordoi
Stimulation of microglia leads to a rapid antidepressant effect by triggering astrocytic P2Y1Rs and promoting BDNF-mediated neurogenesis in the hippocampus
Brain Behavior and Immunity 2025cited by 10position: middledoi
Exploring the obesity paradox in chronic respiratory disease: the mediating effect of triglyceride-glucose index on mortality.
2025cited by 3position: contributordoi
NHANES-based assessment of neutrophil-percentage-to-albumin and neutrophil-to-lymphocyte ratios as moderate predictors of mortality in adults with chronic respiratory diseases.
2025cited by 1position: contributordoi
Prevalence and Control of Diabetes Among US Adults.
2025cited by 0position: contributordoi
Triglyceride-glucose index as an independent predictor of mortality in patients with chronic respiratory diseases.
2025cited by 0position: contributordoi
Association between the triglyceride-glucose index and mortality in the asthma population.
2025cited by 0position: contributordoi
Association between the systemic inflammation response index and all-cause mortality in patients with chronic respiratory diseases: A nationwide cohort study from the NHANES 2001–2018
Chronic Respiratory Disease 2025cited by 0position: contributordoi
Epigenetic control of skeletal muscle atrophy
Cellular & Molecular Biology Letters 2024cited by 25position: middledoi
Association between the systemic inflammation response index and mortality in the asthma population.
2024cited by 8position: contributordoi
S1PR2 is Important for Cigarette Smoke-induced Pyroptosis in Human Bronchial Epithelial Cells.
2023cited by 11position: contributordoi
The influence of pyroptosis-related genes on the development of chronic obstructive pulmonary disease.
2023cited by 2position: contributordoi
Histone deacetylase 3 contributes to the antiviral innate immunity of macrophages by interacting with FOXK1 to regulate STAT1/2 transcription
Cell Reports 2022cited by 49position: middledoi
Association between Vitamin D Status and Mortality among Adults with Diabetic Kidney Disease.
2022cited by 10position: contributordoi
KRIBB11: A Promising Drug that Promotes Microglial Process Elongation and Suppresses Neuroinflammation
Frontiers in Pharmacology 2022cited by 9position: middledoi
m<sup>6</sup>A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD.
2021cited by 158position: contributordoi
Glycolysis-Based Genes Are Potential Biomarkers in Thyroid Cancer.
2021cited by 10position: contributordoi
High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer.
2021cited by 1position: contributordoi
Abstract 11489: Oral Rhamnan Sulfate Reduces Vascular Inflammation and Atherosclerotic Plaque Formation
Circulation 2021cited by 0position: middledoi
A <i>TP53</i>-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma.
2020cited by 99position: contributordoi
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.
2020cited by 56position: contributordoi
Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
2020cited by 55position: contributordoi
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma.
2020cited by 51position: contributordoi
A signature of immune-related gene pairs predicts oncologic outcomes and response to immunotherapy in lung adenocarcinoma.
2020cited by 47position: contributordoi
DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications.
2020cited by 37position: contributordoi
AMPK Activity Contributes to G2 Arrest and DNA Damage Decrease via p53/p21 Pathways in Oxidatively Damaged Mouse Zygotes.
2020cited by 21position: contributordoi
Identification of critical genes associated with the development of asthma by co-expression modules construction.
2020cited by 11position: contributordoi
Establishment of rat liver cancer cell lines with different metastatic potential
Scientific Reports 2020cited by 8position: middledoi
EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling
Inflammation Research 2019cited by 49position: middledoi
HDAC2 attenuates airway inflammation by suppressing IL-17A production in HDM-challenged mice.
2019cited by 26position: contributordoi

Grants

Collaborative Research: Observational and Numerical Modeling Studies of Rain Microphysics
NSF1901593$318,7492019–2024PIRePORTER
On questions around reconstruction program
NSF1764157$220,0002018–2024PIRePORTER
Subfactors and conformal field theory
NSF1069309$177,0012011–2014PIRePORTER
Subfactors and conformal field theories
NSF0800521$140,0252008–2011PIRePORTER
Operator Algebras and Algebraic Conformal Field Theories
NSF0457651$108,0362005–2008PIRePORTER
Operator Algebras and Conformal Field Theories
NSF0200770$106,3052002–2006PIRePORTER
Subfactors from Coset Conformal Field Theories
NSF9820935$66,2581999–2003PIRePORTER

Frequent collaborators

Ling Lin · Huazhong University of Science and Technology5 papers (2020–2022)Lei Jiang · Jiangxi University of Technology3 papers (2017–2018) · 3 papers (2022–2025)Jianbin Su · Nantong University2 papers (2022–2025)Xu Lu · University of California, Davis2 papers (2022–2025)Pan Jiang · Jilin University2 papers (2018–2018) · 2 papers (2014–2022)Lei Zhang · Guangzhou University of Chinese Medicine2 papers (2017–2017)Pan Jiang · Fudan University2 papers (2017–2017)Dongsheng Fei · Harbin Medical University2 papers (2018–2018)Hongxiang Hong · Nantong University2 papers (2022–2025)Lifang Zhao · Binzhou Medical University1 papers (2014–2014)Chunlei Peng · Nantong University1 papers (2024–2024)Fangbing Du · Anhui Medical University1 papers (2017–2017)Jianying He · First Affiliated Hospital of Jiangxi Medical College1 papers (2019–2019)Xing Yin · University of Houston1 papers (2018–2018)Qun Lu · Nantong University1 papers (2022–2022)Ashish Kurundkar · University of Alabama at Birmingham1 papers (2012–2012)Águeda González‐Rodríguez · Instituto de Investigaciones Biomédicas Sols-Morreale1 papers (2021–2021)Juan I. Remon · New York University1 papers (2012–2012)